Kurv Yield Premium Strategy Tesla (TSLA) ETF(TSLP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TSLP Kurv Yield Premium Strategy Tesla (TSLA) ETF

未开盘 09-26 16:00:00 EDT

23.95

-0.05

-0.21%

最高24.11	最低23.86	成交量5,849
今开23.93	昨收24.00	日振幅1.04%
总市值455.05万	流通市值455.05万	总股本19.00万
成交额14.03万	换手率3.08%	流通股本19.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TSLP","market":"US","secType":"STK","nameCN":"Kurv Yield Premium Strategy Tesla (TSLA) ETF","latestPrice":23.95,"timestamp":1727380800000,"preClose":24,"halted":0,"volume":5849,"delay":0,"floatShares":190000,"shares":190000,"eps":0,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.05,"latestTime":"09-26 16:00:00 EDT","open":23.93,"high":24.11,"low":23.86,"amount":140274.75381,"amplitude":0.010417,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"exchange":"AMEX","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1727424000000},"adr":0,"adjPreClose":24,"sharesOutstanding":190000,"nav":24.02,"aum":4563800,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":25.03,"preClose":24,"latestTime":"08:49 EDT","volume":1,"amount":25.03,"timestamp":1727354991086},"volumeRatio":0.44538,"impliedVol":0.0196,"impliedVolPercentile":0.063},"requestUrl":"/m/hq/s/TSLP/tweets","defaultTab":"tweets","newsList":[{"id":"2462143721","title":"和铂医药公布2024年中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2462143721","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462143721?lang=zh_cn&edition=full","pubTime":"2024-08-28 17:51","pubTimestamp":1724838660,"startTime":"0","endTime":"0","summary":"中国苏州、美国马萨诸塞州剑桥和荷兰鹿特丹2024年8月28日 /美通社/ -- 和铂医药，一家专注于肿瘤及免疫领域创新抗体疗法发现、开发及商业化的全球生物医药公司，今日公布截至2024年6月30日的中期业绩。2023年3月，公司宣布其III期临床试验取得积极研究结果。2024年1月，普鲁苏拜单抗联合PD-1抑制剂治疗晚期结直肠癌的受试者开始入组。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4493199_ZH93199_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4107","NEN","BK4588","BK4006","TSLP","BK1583","BK1161","PK","BK4233","BK4205","02142","LU0053666078.USD","BK4218","BK4590","HCC","L","BK4181","BK1574","BK4585"],"gpt_icon":0},{"id":"2462740963","title":"中国生物制药(01177)：“TQC3721(PDE3/4抑制剂)”、“TQC2731(TSLP单抗)”共3项研究数据在ERS 2024公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2462740963","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462740963?lang=zh_cn&edition=full","pubTime":"2024-08-26 16:51","pubTimestamp":1724662295,"startTime":"0","endTime":"0","summary":"中国生物制药(01177)发布公告，集团开发的两款创新药“TQC3721(PDE3...","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_27.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_27.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1170547.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1515","BK1191","BK1589","TSLP","01177","BK1521"],"gpt_icon":0},{"id":"2453078842","title":"【辉瑞(PFE.US)两款三抗在中国启动2期临床 治疗特应性皮炎】智通财经APP获悉，7月23日，中国药物临床试验登记与信息公示平台显示，辉瑞(PFE.","url":"https://stock-news.laohu8.com/highlight/detail?id=2453078842","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453078842?lang=zh_cn&edition=full","pubTime":"2024-07-24 16:31","pubTimestamp":1721809919,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0868494617.USD","IE00BBT3K403.USD","SG9999001176.USD","BK4550","LU0321505868.SGD","LU1883839398.USD","SG9999001176.SGD","SG9999013999.USD","LU1894683264.USD","TSLP","BK1141","LU1057294990.SGD","BK4007","BK4534","BK4592","IE00BLSP4452.SGD","BK4533","LU0170899867.USD","SG9999002224.SGD","LU0058720904.USD","IE00B19Z3581.USD","LU1894683348.USD","LU0234572021.USD","IE0002270589.USD","BK1576","BK4588","LU0456855351.SGD","LU1066053197.SGD","LU0122379950.USD","BK4585","LU1023059063.AUD","SGXZ57979304.SGD","BK1583","SG9999002232.USD","PFE","IE00B19Z3B42.SGD","SG9999003800.SGD","03347","SG9999011175.SGD","LU0289739699.SGD","LU1066051498.USD","BK4568","IE00BLSP4239.USD","BK4581","LU0321505439.SGD"],"gpt_icon":0},{"id":"2443939986","title":"6月13日中国国家药监局药品审评中心（CDE）官网公示辉瑞两款1类新药获批临床二者均拟开发治疗成人中度至重度特应性皮炎。根据辉瑞公开资料这两款产品均为三特异性抗体为该公司炎症和免疫管线中的新分子实体。","url":"https://stock-news.laohu8.com/highlight/detail?id=2443939986","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2443939986?lang=zh_cn&edition=full","pubTime":"2024-06-15 10:55","pubTimestamp":1718420112,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B19Z3B42.SGD","SGXZ57979304.SGD","SG9999002224.SGD","BK4017","BK4592","LU1066051498.USD","BK4550","LU0122379950.USD","BK4581","IE00BLSP4452.SGD","SG9999001176.SGD","LU0170899867.USD","LU0321505868.SGD","LU0058720904.USD","LU1023059063.AUD","SG9999001176.USD","TSLP","LU1057294990.SGD","LU1066053197.SGD","SG9999002232.USD","BK4585","SG9999011175.SGD","BK4007","BK4533","IE00B19Z3581.USD","BK4534","BK4568","LU0321505439.SGD","PFE","CDE","IE0002270589.USD","LU0289739699.SGD","LU0456855351.SGD","IE00BLSP4239.USD","SG9999013999.USD","IE00BBT3K403.USD","SG9999003800.SGD","LU0234572021.USD","LU0868494617.USD","BK4588"],"gpt_icon":0},{"id":"2443295933","title":"【辉瑞(PFE.US)两款三抗新药在中国获批临床】智通财经APP获悉，6月13日，中国国家药监局药品审评中心（CDE）官网公示，辉瑞(PFE.","url":"https://stock-news.laohu8.com/highlight/detail?id=2443295933","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2443295933?lang=zh_cn&edition=full","pubTime":"2024-06-15 09:39","pubTimestamp":1718415541,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4581","SGXZ57979304.SGD","IE00B19Z3B42.SGD","LU0058720904.USD","SG9999002232.USD","LU0321505868.SGD","BK4534","BK4568","TSLP","SG9999011175.SGD","LU0289739699.SGD","BK4592","LU0321505439.SGD","SG9999001176.USD","LU1057294990.SGD","BK4533","BK4007","SG9999013999.USD","IE0002270589.USD","IE00B19Z3581.USD","SG9999002224.SGD","IE00BBT3K403.USD","BK4550","IE00BLSP4452.SGD","LU1066051498.USD","LU1066053197.SGD","LU0170899867.USD","SG9999001176.SGD","BK4588","IE00BLSP4239.USD","LU0456855351.SGD","LU0234572021.USD","LU0868494617.USD","CDE","BK4585","SG9999003800.SGD","LU1023059063.AUD","PFE","BK4017","LU0122379950.USD"],"gpt_icon":0},{"id":"2427592040","title":"被赚差价的恒瑞医药，与火爆的TSLP靶点","url":"https://stock-news.laohu8.com/highlight/detail?id=2427592040","media":"氨基观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2427592040?lang=zh_cn&edition=full","pubTime":"2024-04-15 13:48","pubTimestamp":1713160107,"startTime":"0","endTime":"0","summary":"3个月前，海外药企的一起常规收购案，让恒瑞医药陷入了尴尬的处境。当时，GSK宣布收购Aiolos Bio，代价是10亿美元首付款以及4亿美元的监管里程碑款。而Aiolos Bio唯一的管线TSLP单抗AIO-001（SHR-1905），引进自恒瑞医药。去年8月份，前者与恒瑞医药达成合作协议，获得了该款药物的海外权益，代价是：2500万美元首付款，以...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OTmZVjsn1MeBCycuhobLUmmDJHU3ZuNlTiGB7geNqEXCwAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OTmZVjsn1MeBCycuhobLUmmDJHU3ZuNlTiGB7geNqEXCwAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240415A04QTU00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240415A04QTU00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["TSLP"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0394},{"period":"1month","weight":0.09},{"period":"3month","weight":0.134},{"period":"6month","weight":0.2072},{"period":"1year","weight":-0.0408},{"period":"ytd","weight":-0.1536}],"compareEarnings":[{"period":"1week","weight":0.0154},{"period":"1month","weight":0.0165},{"period":"3month","weight":0.0433},{"period":"6month","weight":0.0898},{"period":"1year","weight":0.3385},{"period":"ytd","weight":0.1993}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"exchange":"AMEX","name":"Kurv Yield Premium Strategy Tesla (TSLA) ETF","nameEN":"Kurv Yield Premium Strategy Tesla (TSLA) ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.1","shortVersion":"4.28.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kurv Yield Premium Strategy Tesla (TSLA) ETF(TSLP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kurv Yield Premium Strategy Tesla (TSLA) ETF(TSLP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kurv Yield Premium Strategy Tesla (TSLA) ETF,TSLP,Kurv Yield Premium Strategy Tesla (TSLA) ETF股票,Kurv Yield Premium Strategy Tesla (TSLA) ETF股票老虎,Kurv Yield Premium Strategy Tesla (TSLA) ETF股票老虎国际,Kurv Yield Premium Strategy Tesla (TSLA) ETF行情,Kurv Yield Premium Strategy Tesla (TSLA) ETF股票行情,Kurv Yield Premium Strategy Tesla (TSLA) ETF股价,Kurv Yield Premium Strategy Tesla (TSLA) ETF股市,Kurv Yield Premium Strategy Tesla (TSLA) ETF股票价格,Kurv Yield Premium Strategy Tesla (TSLA) ETF股票交易,Kurv Yield Premium Strategy Tesla (TSLA) ETF股票购买,Kurv Yield Premium Strategy Tesla (TSLA) ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kurv Yield Premium Strategy Tesla (TSLA) ETF(TSLP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kurv Yield Premium Strategy Tesla (TSLA) ETF(TSLP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}